Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monolaurin Cream for Congenital Ichthyosis
NCT00004690Phase 3Completed
- Sponsor
- Cellegy Pharmaceuticals, Inc.
- Start
- Sep 1996
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of monolaurin in nonbullous congenital ichthyosiform erythroderma (NCIE), sponsored by Cellegy Pharmaceuticals, Inc.. Started Sep 1996; status: completed.
02
Drugs
monolaurin
03
Conditions
nonbullous congenital ichthyosiform erythroderma (NCIE)
Beyond the preview
Go deeper on NCT00004690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004690.